824 related articles for article (PubMed ID: 25629589)
1. Role of translocator protein density, a marker of neuroinflammation, in the brain during major depressive episodes.
Setiawan E; Wilson AA; Mizrahi R; Rusjan PM; Miler L; Rajkowska G; Suridjan I; Kennedy JL; Rekkas PV; Houle S; Meyer JH
JAMA Psychiatry; 2015 Mar; 72(3):268-75. PubMed ID: 25629589
[TBL] [Abstract][Full Text] [Related]
2. Neuroinflammation After COVID-19 With Persistent Depressive and Cognitive Symptoms.
Braga J; Lepra M; Kish SJ; Rusjan PM; Nasser Z; Verhoeff N; Vasdev N; Bagby M; Boileau I; Husain MI; Kolla N; Garcia A; Chao T; Mizrahi R; Faiz K; Vieira EL; Meyer JH
JAMA Psychiatry; 2023 Aug; 80(8):787-795. PubMed ID: 37256580
[TBL] [Abstract][Full Text] [Related]
3. Elevated Translocator Protein in Anterior Cingulate in Major Depression and a Role for Inflammation in Suicidal Thinking: A Positron Emission Tomography Study.
Holmes SE; Hinz R; Conen S; Gregory CJ; Matthews JC; Anton-Rodriguez JM; Gerhard A; Talbot PS
Biol Psychiatry; 2018 Jan; 83(1):61-69. PubMed ID: 28939116
[TBL] [Abstract][Full Text] [Related]
4. Association of translocator protein total distribution volume with duration of untreated major depressive disorder: a cross-sectional study.
Setiawan E; Attwells S; Wilson AA; Mizrahi R; Rusjan PM; Miler L; Xu C; Sharma S; Kish S; Houle S; Meyer JH
Lancet Psychiatry; 2018 Apr; 5(4):339-347. PubMed ID: 29496589
[TBL] [Abstract][Full Text] [Related]
5. Inflammation in the Neurocircuitry of Obsessive-Compulsive Disorder.
Attwells S; Setiawan E; Wilson AA; Rusjan PM; Mizrahi R; Miler L; Xu C; Richter MA; Kahn A; Kish SJ; Houle S; Ravindran L; Meyer JH
JAMA Psychiatry; 2017 Aug; 74(8):833-840. PubMed ID: 28636705
[TBL] [Abstract][Full Text] [Related]
6. Translocator Protein Distribution Volume Predicts Reduction of Symptoms During Open-Label Trial of Celecoxib in Major Depressive Disorder.
Attwells S; Setiawan E; Rusjan PM; Xu C; Hutton C; Rafiei D; Varughese B; Kahn A; Kish SJ; Vasdev N; Houle S; Meyer JH
Biol Psychiatry; 2020 Oct; 88(8):649-656. PubMed ID: 32402468
[TBL] [Abstract][Full Text] [Related]
7. Translocator protein (18kDa TSPO) binding, a marker of microglia, is reduced in major depression during cognitive-behavioral therapy.
Li H; Sagar AP; Kéri S
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Apr; 83():1-7. PubMed ID: 29269262
[TBL] [Abstract][Full Text] [Related]
8. Monoamine Oxidase B Total Distribution Volume in the Prefrontal Cortex of Major Depressive Disorder: An [11C]SL25.1188 Positron Emission Tomography Study.
Moriguchi S; Wilson AA; Miler L; Rusjan PM; Vasdev N; Kish SJ; Rajkowska G; Wang J; Bagby M; Mizrahi R; Varughese B; Houle S; Meyer JH
JAMA Psychiatry; 2019 Jun; 76(6):634-641. PubMed ID: 30840042
[TBL] [Abstract][Full Text] [Related]
9. Microglial markers in the frontal cortex are related to cognitive dysfunctions in major depressive disorder.
Li H; Sagar AP; Kéri S
J Affect Disord; 2018 Dec; 241():305-310. PubMed ID: 30142589
[TBL] [Abstract][Full Text] [Related]
10. In vivo imaging translocator protein (TSPO) in autism spectrum disorder.
Simpson D; Gharehgazlou A; Da Silva T; Labrie-Cleary C; Wilson AA; Meyer JH; Mizrahi R; Rusjan PM
Neuropsychopharmacology; 2022 Jun; 47(7):1421-1427. PubMed ID: 35383319
[TBL] [Abstract][Full Text] [Related]
11. Neuroinflammation in healthy aging: a PET study using a novel Translocator Protein 18kDa (TSPO) radioligand, [(18)F]-FEPPA.
Suridjan I; Rusjan PM; Voineskos AN; Selvanathan T; Setiawan E; Strafella AP; Wilson AA; Meyer JH; Houle S; Mizrahi R
Neuroimage; 2014 Jan; 84():868-75. PubMed ID: 24064066
[TBL] [Abstract][Full Text] [Related]
12. A double-blind placebo-controlled trial of minocycline on translocator protein distribution volume in treatment-resistant major depressive disorder.
Attwells S; Setiawan E; Rusjan PM; Xu C; Kish SJ; Vasdev N; Houle S; Santhirakumar A; Meyer JH
Transl Psychiatry; 2021 May; 11(1):334. PubMed ID: 34052828
[TBL] [Abstract][Full Text] [Related]
13. Replicating predictive serum correlates of greater translocator protein distribution volume in brain.
Attwells S; Setiawan E; Wilson AA; Rusjan PM; Miler L; Xu C; Hutton C; Husain MI; Kish S; Vasdev N; Houle S; Meyer JH
Neuropsychopharmacology; 2020 May; 45(6):925-931. PubMed ID: 31683271
[TBL] [Abstract][Full Text] [Related]
14. Microglia imaging in methamphetamine use disorder: a positron emission tomography study with the 18 kDa translocator protein radioligand [F-18]FEPPA.
Rathitharan G; Truong J; Tong J; McCluskey T; Meyer JH; Mizrahi R; Warsh J; Rusjan P; Kennedy JL; Houle S; Kish SJ; Boileau I
Addict Biol; 2021 Jan; 26(1):e12876. PubMed ID: 32017280
[TBL] [Abstract][Full Text] [Related]
15. Imaging neuroinflammation in gray and white matter in schizophrenia: an in-vivo PET study with [18F]-FEPPA.
Kenk M; Selvanathan T; Rao N; Suridjan I; Rusjan P; Remington G; Meyer JH; Wilson AA; Houle S; Mizrahi R
Schizophr Bull; 2015 Jan; 41(1):85-93. PubMed ID: 25385788
[TBL] [Abstract][Full Text] [Related]
16. Disease activity in rheumatoid arthritis is inversely related to cerebral TSPO binding assessed by [
Forsberg A; Lampa J; Estelius J; Cervenka S; Farde L; Halldin C; Lekander M; Olgart Höglund C; Kosek E
J Neuroimmunol; 2019 Sep; 334():577000. PubMed ID: 31260948
[TBL] [Abstract][Full Text] [Related]
17. Quantitative imaging of neuroinflammation in human white matter: a positron emission tomography study with translocator protein 18 kDa radioligand, [18F]-FEPPA.
Suridjan I; Rusjan PM; Kenk M; Verhoeff NP; Voineskos AN; Rotenberg D; Wilson AA; Meyer JH; Houle S; Mizrahi R
Synapse; 2014 Nov; 68(11):536-47. PubMed ID: 25043159
[TBL] [Abstract][Full Text] [Related]
18. Brain monoamine oxidase A binding in major depressive disorder: relationship to selective serotonin reuptake inhibitor treatment, recovery, and recurrence.
Meyer JH; Wilson AA; Sagrati S; Miler L; Rusjan P; Bloomfield PM; Clark M; Sacher J; Voineskos AN; Houle S
Arch Gen Psychiatry; 2009 Dec; 66(12):1304-12. PubMed ID: 19996035
[TBL] [Abstract][Full Text] [Related]
19. Markers of central inflammation in major depressive disorder: A systematic review and meta-analysis of studies examining cerebrospinal fluid, positron emission tomography and post-mortem brain tissue.
Enache D; Pariante CM; Mondelli V
Brain Behav Immun; 2019 Oct; 81():24-40. PubMed ID: 31195092
[TBL] [Abstract][Full Text] [Related]
20. Imaging Microglial Activation in Untreated First-Episode Psychosis: A PET Study With [
Hafizi S; Tseng HH; Rao N; Selvanathan T; Kenk M; Bazinet RP; Suridjan I; Wilson AA; Meyer JH; Remington G; Houle S; Rusjan PM; Mizrahi R
Am J Psychiatry; 2017 Feb; 174(2):118-124. PubMed ID: 27609240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
